Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
80.1M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
4.95M
-
Shares change
-
+1.43M
-
Total reported value, excl. options
-
$10.9M
-
Value change
-
+$2.05M
-
Put/Call ratio
-
0.11
-
Number of buys
-
56
-
Number of sells
-
-26
-
Price
-
$2.20
Significant Holders of Mind Medicine (MindMed) Inc. - Common Shares (MNMD) as of Q4 2022
106 filings reported holding MNMD - Mind Medicine (MindMed) Inc. - Common Shares as of Q4 2022.
Mind Medicine (MindMed) Inc. - Common Shares (MNMD) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.95M shares
of 80.1M outstanding shares and own 6.18% of the company stock.
Largest 10 shareholders include Alyeska Investment Group, L.P. (1.1M shares), VANGUARD GROUP INC (594K shares), Merit Financial Group, LLC (540K shares), BlackRock Inc. (452K shares), GEODE CAPITAL MANAGEMENT, LLC (282K shares), MILLENNIUM MANAGEMENT LLC (249K shares), Busey Wealth Management (244K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (181K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (166K shares), and AdvisorShares Investments LLC (113K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.